Adult Vaccination
Vaccination helps reduce the risk of serious vaccine-preventable infections. Adults may need different vaccines or boosters based on age, health conditions, occupation, travel and previous vaccination history.
Understanding Adult Vaccination
Adult vaccination is an important part of preventive healthcare. For people with chronic respiratory conditions, older adults and others at increased risk of complications, vaccination may be an important part of a broader plan to reduce the risk of severe respiratory and other infections. The appropriate vaccines and timing should be decided after reviewing the individual’s age, medical history, previous doses, allergies and current recommendations.
Why adult vaccination matters
Vaccines can help prevent infections and reduce the risk of complications. Adults may need routine vaccination, catch-up vaccination or booster doses at different stages of life. People with chronic illnesses may also have additional vaccination considerations, so the schedule should be individualized rather than treated as a one-size-fits-all plan.
Vaccination and respiratory health
Vaccination can be particularly relevant when respiratory infections may carry greater risk of complications. Depending on age and individual risk factors, clinicians may consider vaccines such as influenza, pneumococcal, COVID-19 and respiratory syncytial virus (RSV), along with other routine adult vaccines when indicated.
Before vaccination
Bring available vaccination records and tell the clinician about current medicines, previous vaccine reactions, allergies, pregnancy or plans for pregnancy, immune conditions and significant medical problems. The final recommendation should be based on the individual clinical situation and the current local guidance.
What may be assessed
- Review age-appropriate vaccines and booster requirements
- Consider additional vaccines when medical conditions or other risk factors apply
- Check previous vaccination records before deciding on additional doses
- Discuss pregnancy, immune conditions, allergies, travel and other special situations with a qualified clinician
- Use current national and clinical guidance when deciding which vaccines are appropriate
Adult vaccination in Jalgaon
Patients in Jalgaon looking for adult vaccination guidance can use this page as a general reference before consultation. At Parsh Chest Clinic, vaccination decisions are based on the individual’s age, health conditions, vaccination history, risk factors and current clinical guidance.
CDC Adult Immunization Schedule — 2025
This table is a simplified reference based on the U.S. Centers for Disease Control and Prevention (CDC) adult schedule for ages 19 years or older. Recommendations can depend on age, medical conditions, previous vaccination and other indications. It is not an individualized vaccination plan and should not replace current local clinical guidance.
| Vaccine | 19–26 years | 27–49 years | 50–64 years | 65+ years |
|---|---|---|---|---|
| COVID-19 | See current CDC notes | See current CDC notes | See current CDC notes | See current CDC notes |
| Influenza | 1 dose annually | 1 dose annually | 1 dose annually | 1 dose annually; some products are preferred for older adults |
| RSV | Pregnancy-specific recommendations may apply | Pregnancy-specific recommendations may apply | 50–74 years when indicated | Recommended for adults 75+; see CDC notes |
| Tdap / Td | 1 Tdap, then Td/Tdap booster every 10 years; special indications may apply | Booster every 10 years; special indications may apply | Booster every 10 years | Booster every 10 years |
| MMR | 1 or 2 doses depending on indication | 1 or 2 doses depending on indication | Special indications may apply | Special indications may apply |
| Varicella | 2 doses when indicated | 2 doses when indicated | 2 doses when indicated | 2 doses when indicated |
| Zoster (RZV) | 2 doses for immunocompromising conditions when indicated | 2 doses for immunocompromising conditions when indicated | 2 doses when indicated | 2 doses |
| HPV | 2 or 3 doses depending on age at initial vaccination or condition | Through age 45 based on shared clinical decision-making | Not routinely recommended by age alone | Not routinely recommended by age alone |
| Pneumococcal | Risk-based recommendations may apply | Risk-based recommendations may apply | See CDC notes and risk factors | See CDC notes and risk factors |
| Hepatitis A | 2, 3 or 4 doses depending on vaccine | 2, 3 or 4 doses depending on vaccine | Risk-based recommendations may apply | Risk-based recommendations may apply |
| Hepatitis B | 2, 3 or 4 doses depending on vaccine or condition | 2, 3 or 4 doses depending on vaccine or condition | 2, 3 or 4 doses depending on vaccine or condition | 2, 3 or 4 doses depending on vaccine or condition |
| Meningococcal | 1 or 2 doses depending on indication | Risk-based recommendations may apply | Risk-based recommendations may apply | Risk-based recommendations may apply |
| Hib | 1 or 3 doses depending on indication | Risk-based recommendations may apply | Risk-based recommendations may apply | Risk-based recommendations may apply |
| Mpox | 2 doses when indicated | 2 doses when indicated | 2 doses when indicated | 2 doses when indicated |
| Polio (IPV) | Complete 3-dose series if incompletely vaccinated | Complete series if incompletely vaccinated and indicated | Complete series if incompletely vaccinated and indicated | Complete series if incompletely vaccinated and indicated |
Discuss your vaccination needs with the clinic.
This information is general and does not replace an individual vaccination assessment.